ClinicalTrials.gg
CompletedNCT06326983Updated May 18, 2026

Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery

An interventional study of Dexmedetomidine and Acetaminophen in Tonsillitis, Post-operative Nausea and Vomiting (PONV) and Emergence Delirium, sponsored by Boston Children's Hospital. Completed at 1 site in United States. Open to participants aged 3 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by Boston Children's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
3 Years to 17 Years
Sex
All
01

Study summary

This is a prospective, randomized, controlled, non-inferiority study of patients undergoing tonsil surgeries at Boston Children's Hospital Waltham. The overall aim is to evaluate the efficacy of an opioid anesthetic plan (morphine, ketorolac, and acetaminophen versus an opioid sparing anesthetic plan (dexmedetomidine, ketorolac and acetaminophen) for perioperative analgesia and recovery time in patients undergoing tonsillectomies and tonsillotomies at Boston Children's Hospital Waltham. Secondary measures include rescue opioids administered in post-anesthesia care unit (PACU), re-operation secondary to bleeding, emergence delirium, post-operative nausea and vomiting, intraoperative hemodynamics, intraoperative vasopressor administration, and length of procedure.

02

Conditions studied

  • Tonsillitis
  • Post-operative Nausea and Vomiting (PONV)
  • Emergence Delirium
  • Opioid Analgesic Adverse Reaction
  • Anesthesia
  • Pain
03

In context

Tonsillitis

103 studies on the registry are indexed under Tonsillitis; 12 are open to participants now.

This study's enrollment of 62 is below the median of 100 across 87 interventional studies indexed under Tonsillitis.

Browse Tonsillitis studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 608 studies on the registry; 147 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • American Society of Anesthesia classification status I-III
  • Ages 3 years to 17 years
  • Scheduled for tonsillectomy or tonsillotomy with or without adenoidectomy at Boston Children's Hospital Waltham

Exclusion criteria

Exclusion Criteria:

  • Patients not scheduled for primary tonsillectomy/tonsillotomy.
  • Patients with known coagulopathies
  • Patients with previous chronic pain syndromes
  • Patients with any condition/indication that would prevent them from being able to be randomized (i.e. allergy to one of the study medications)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    Opioid-Sparing Anesthetic Plan

    For their tonsil surgery, subjects will receive Dexmedetomidine (1mcg/kg bolus given intravenously at induction of anesthesia) and Acetaminophen (12.5mg/kg with a maximum dose of 1 gram given intravenously at induction of anesthesia). Ketorolac 0.5mg/kg with a max dose of 30mg given intravenously at the end of surgery. No opioids will be given during the procedure.

    Drug: Dexmedetomidine · Drug: Acetaminophen · Drug: Ketorolac

  • Active comparator
    Opioid Anesthetic Plan

    For their tonsil surgery, subjects will receive Morphine (0.1mg/kg given intravenously at induction of anesthesia) and Acetaminophen (12.5mg/kg with a maximum dose of 1 gram given intravenously at induction of anesthesia). Ketorolac 0.5mg/kg with a max dose of 30mg intravenously at the end of surgery.

    Drug: Acetaminophen · Drug: Ketorolac · Drug: Morphine

Interventions

  • Dexmedetomidine (1mcg/kg bolus given intravenously at induction of anesthesia

    Also known as: Precedex

  • Acetaminophen (12.5mg/kg with a maximum dose of 1 gram given intravenously at induction of anesthesia).

    Also known as: Ofirmev

  • Ketorolac 0.5mg/kg with a max dose of 30mg intravenously at the end of surgery.

    Also known as: Toradol

  • Morphine (0.1mg/kg given intravenously at induction of anesthesia)

06

What researchers measure

Primary outcomes

  1. Median Pain Scores in the Post-Anesthesia Care Unit

    Median Pain Scores in the Post-Anesthesia Care Unit measured by the numeric rating scale (NRS), Wong-Baker Faces scale or FLACC (Face, Legs, Activity, Cry, Consolability) scale as indicated based on patient age and development. All scales are done on a 0-10 point scale with 0 being no pain and 10 being the highest pain.

    Time frame: entry to post-anesthesia care unit to 2-6 hours post-operatively

  2. Post-operative pain at 12-24 hours

    Pain categorized as none, mild, moderate, and severe. Taken from the routine follow-up nursing phone call.

    Time frame: 12-24 hours post-operatively

  3. Post Operative Anesthesia Unit Length of Stay (hours)

    Length of time spent in the Post Operative Anesthesia Unit after tonsil surgery

    Time frame: From entry to the Post Anesthesia Care Unit to exit from the Post-Anesthesia Care Unit. Assessed for up to 8 hours on the date of surgery

Secondary outcomes

  1. Opioid rescue medication administration

    Opioid rescue medications administered (reported as oral morphine equivalents)

    Time frame: surgery end to 2-6 hours post-operatively

  2. Emergence Delirium

    Incidence of emergence delirium defined as a score ≥ 10 on the Pediatric Anesthesia Emergence Delirium Scale. Scores range 0-20 with 0 being no agitation/delirium to 20 being the highest level.

    Time frame: surgery end to 2-6 hours post-operatively

  3. Post-operative nausea and vomiting

    Incidence of episodes of emesis or administration of anti-emetics in the post-anesthesia care unit

    Time frame: surgery end to 2-6 hours post-operatively

  4. Procedure length (minutes)

    from incision time to patient being wheeled out of the operating room

    Time frame: 0-60 minutes

  5. Intraoperative Blood pressure (mmHg)

    Range of systolic blood pressure within 10 minutes of anesthesia induction

    Time frame: 10 minutes

  6. Intraoperative Heart rate (beats per second)

    Range of heart rate within 10 minutes of anesthesia induction

    Time frame: 10 minutes

  7. Vasopressor administration

    Intraoperative administration of vasopressors

    Time frame: 0-60 minutes

07

Study locations

1 site
  • Boston Children's Hospital
    Waltham, Massachusetts 02453, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06326983
Responsible party
Arielle Mizrahi-Arnaud (MD, Anesthesia, Critical Care and Pain Medicine, Principal Investigator, Boston Children's Hospital) — Principal investigator
First posted
Mar 25, 2024
Start date
May 9, 2024
Primary completion
Jan 30, 2026
Completion
Mar 1, 2026
Last update
May 18, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Dexmedetomidine

Start the discussion